Literature DB >> 26729823

Pseudomyxoma peritonei with intrathoracic extension: a rare disease with rarer presentation from low-grade mucinous adenocarcinoma of the appendix.

Raktim K Ghosh1, Mey Somasundaram1, Keyvan Ravakhah1, Chandra Hassan2.   

Abstract

Pseudomyxoma peritonei is an extremely rare disease, characterised by mucinous ascites and implants, diffusely involving the peritoneal surfaces. Recent pathological and genetic advances indicate that they mostly originate from an appendiceal adenoma or adenocarcinoma. The successful treatment of peritoneal carcinomatosis requires a comprehensive management plan including cytoreductive surgery, intraoperative intraperitoneal heated chemotherapy and postoperative systemic chemotherapy. It is extremely rare to have intrathoracic spread of the disease at initial presentation. Some of the possible hypotheses of neoplastic cells spreading into the pleural cavity include congenital or acquired pleura-peritoneal communications, invasion of lymphovascular space and, rarely, through direct invasion of the diaphragm. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 26729823      PMCID: PMC4716424          DOI: 10.1136/bcr-2015-211076

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.

Authors:  Anh Dang; Paul Mansfield; Burak Ilsin; Curtis Hightower; Natarajan Aravindan; David Rice; Bernhard Riedel
Journal:  J Cardiothorac Vasc Anesth       Date:  2006-08-23       Impact factor: 2.628

2.  Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.

Authors:  Marco Vaira; Tommaso Cioppa; Giovanni DE Marco; Camilla Bing; Silvia D'Amico; Michelina D'Alessandro; Giammaria Fiorentini; Michele DE Simone
Journal:  In Vivo       Date:  2009 Jul-Aug       Impact factor: 2.155

Review 3.  Pseudomyxoma peritonei syndrome.

Authors:  P H Sugarbaker; B M Ronnett; A Archer; A M Averbach; R Bland; D Chang; R R Dalton; S E Ettinghausen; P Jacquet; J Jelinek; P Koslowe; R J Kurman; B Shmookler; A D Stephens; M A Steves; O A Stuart; S White; C M Zahn; F A Zoetmulder
Journal:  Adv Surg       Date:  1996

4.  Current concepts in pseudomyxoma peritonei.

Authors:  Norman John Carr
Journal:  Ann Pathol       Date:  2014-02-15       Impact factor: 0.407

Review 5.  Pleuropulmonary involvement in pseudomyxoma peritonei: morphologic assessment and literature review.

Authors:  Kim R Geisinger; Edward A Levine; Perry Shen; Robert F Bradley
Journal:  Am J Clin Pathol       Date:  2007-01       Impact factor: 2.493

6.  Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.

Authors:  S R Pestieau; J Esquivel; P H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2000-04       Impact factor: 5.344

Review 7.  Mucinous neoplasms of the appendix and peritoneum.

Authors:  Nicole C Panarelli; Rhonda K Yantiss
Journal:  Arch Pathol Lab Med       Date:  2011-10       Impact factor: 5.534

8.  [Pseudomyxoma peritonei spread into the right inguinal hernia sac--a case report].

Authors:  Paulina Cichon; Kamil Drucis; Michal Kakol; Tomasz Jastrzebski; Tomasz Polec
Journal:  Pol Merkur Lekarski       Date:  2013-10
  8 in total
  1 in total

1.  Apatinib for treatment of a pseudomyxoma peritonei patient after surgical treatment and hyperthermic intraperitoneal chemotherapy: A case report.

Authors:  Rong Huang; Xiu-Ling Shi; Yun-Fei Wang; Fei Yang; Ting-Tao Wang; Cun-Xu Peng
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.